Pfizer Inc (PFE)

205,190.00
+9,190.00(+4.69%)
  • Volume:
    253
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    205,190.00 - 205,190.00
  • Type:Equity
  • Market:Colombia
  • ISIN:US7170811035

PFE Overview

Prev. Close
-
Day's Range
205,190-205,190
Revenue
-
Open
205,190
52 wk Range
155,420-243,000
EPS
-
Volume
253
Market Cap
-
Dividend (Yield)
1.60
(3.15%)
Average Vol. (3m)
259
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
5,610,895,801
Next Earnings Date
-
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyBuyBuy
SummaryStrong BuyStrong BuyStrong Buy
  • It was too late for Pfizer to authorize booster shots for children ages 5 to 11. Many children are infected every day.
    0
    • MERCK continues to rise, but Pfizer falls. That's why Buffett chooses Merck.
      0
      • Pfizer is a dead cat bounce.
        0
        • Pfizer seems attractively positioned technically for a bounce and might try to fill gaps.
          3
          • Pfizer's forward earnings should decline dramatically as there is less of a need for their vaccine and/or their therapeutic drug. 1Q was a "transition" to much lower earnings.
            3
            • why Moderna goes up so quick, but Pfizer can't. I think the insiders manipulate the stock price.
              7
              • just stop
                0
            • solid good company
              5
              • what a dead cat bouncing.
                5
                • 3,6 % deaths it not enough<
                  2
                  • Oops! no $52, only down.
                    6